SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-053355
Filing Date
2021-04-22
Accepted
2021-04-22 06:01:24
Documents
14
Period of Report
2021-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113722d1_8k.htm   iXBRL 8-K 26657
2 EXHIBIT 99.1 tm2113722d1_ex99-1.htm EX-99.1 19489
6 GRAPHIC tm2113722d1_ex99-1img001.jpg GRAPHIC 16739
  Complete submission text file 0001104659-21-053355.txt   248382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20210421.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20210421_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20210421_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2113722d1_8k_htm.xml XML 3485
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21843132
SIC: 2836 Biological Products, (No Diagnostic Substances)